Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)
CUSIP: 761330109
Q1 2014 13F Holders as of 31 Mar 2014
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 104,661,494
- Total 13F shares
- 11,832,924
- Share change
- +11,832,924
- Total reported value
- $372,736,175
- Price per share
- $31.50
- Number of holders
- 65
- Value change
- +$372,736,179
- Number of buys
- 65
Quarterly Holders Quick Answers
What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q2 2014
Recent filing periods for CUSIP 761330109:
Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q1 2014
As of 31 Mar 2014,
Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,832,924 shares.
The largest 10 holders included
Essex Woodlands Health Ventures, Inc., Visium Asset Management, LP, WADDELL & REED FINANCIAL INC, COLUMBIA WANGER ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, Partner Fund Management, L.P., RS INVESTMENT MANAGEMENT CO LLC, FMR LLC, Camber Capital Management LLC, and Zweig-DiMenna Associates LLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2014 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q1 2014 holders
65
Holder diff
64
| Investor | Q3 2025 Shares | Q1 2014 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q1 2014 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.